Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
22
Patentes de invención
22
Propiedad industrial
15
Patentes
11
Derechos de autor
8
Marcas de fábrica
5
Historia
4
México
3
Transferencia de tecnología
3
Aspectos ambientales
2
Biotecnología
2
Biotecnología agrícola
2
Ciencia
2
Criptografía
2
Genes
2
Ingeniería genética
2
Literatura española
2
Marcas
2
Monopolios
2
PATENTES
2
PATENTS
2
Patents
2
Propiedad intelectual
2
Universidades
2
ACADEMIC PRODUCTION
1
ACADEMIC WOMEN
1
ANÁLISIS BIBLIOMÉTRICO
1
Acuerdos (Derecho)
1
Administración pública
1
Agricultura
1
-
8721“…Our findings demonstrate that off-patent medications can skyrocket in price, especially when there are few manufacturers of a given medication.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8722por Cucerea, Manuela, Moscalu, Mihaela, Moldovan, Elena, Santa, Reka, Gall, Zsuzsanna, Suciu, Laura Mihaela, Simon, Marta“…There were no significant differences between groups in frequencies of bronchopulmonary dysplasia, necrotizing enterocolitis and patent ductus arteriosus. Conclusions: Less invasive surfactant administration methods seem to have advantages regarding early need for mechanical ventilation, decreasing morbidities and death rate. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8723“…A completion angiography demonstrated a patent popliteal artery with a 2-vessels patency to the foot. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8724“…All patients were asymptomatic, with patent CFAs, at last follow-up. There was 1 case of surgical site restenosis and 1 reintervention for remote stenosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8725por Tafuri, Alessandro, Panunzio, Andrea, De Mitri, Rita, Benetti, Federico, Gaio, Elisa, Pagliarulo, Vincenzo“…The aim of this study was to evaluate the efficacy of a patent-pending formulation (Pelvipea(®)) composed of micronized palmitoylethanolamide (PEA), hempseed oil, and maritime pine bark dry extract in reducing urothelial inflammation, as well as the effect of each ingredient individually, in order to define the synergistic effect of the three ingredients. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8726por Tang, Ruying, Zhang, Jianjun, Zhang, Rui, Li, Xinyu, Lv, Ruilin, Nan, Haipeng, Liu, Jinlian, Zhao, Zhongpeng, He, Wei, Wang, Linyuan“…Huoxiang Zhengqi Oral Liquid (HZOL) is a classic Chinese patent medicine used in China for more than 1,000 years in treating gastrointestinal and respiratory diseases. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8727por Maruta, Jun“…RESULTS: During roll-while-rotating conditioning, the roll component of the VOR was compensatory to the oscillation about the corresponding axis, but the pitch component was not, initially prominently phase-leading the head pitch motion but subsequently becoming patently phase-delayed. Unidirectional yaw nystagmus, weak but directionally compensatory to the earth-vertical axis rotation, was seen throughout the period of conditioning. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8728por Tang, Tjun Yip, Chong, Tze-Tec, Yap, Charyl Jia Qi, Soon, Shereen Xue Yun, Chan, Sze Ling, Tan, Ru Yu, Yap, Hao Yun, Tay, Hsien Ts’ung, Tan, Chieh-Suai, Barnhill, Scott, Hellinga, David, DeGraw, R Tyler, Finn, Aloke V“…Follow-up will occur for 2 years for those patients whose AVFs remain patent. Pharmacokinetic and histological animal safety studies performed with the Selution™ coating formulation showed prolonged arterial tissue retention of sirolimus with therapeutic levels up to 60 days and non-toxic and rapidly declining blood levels. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8729por Shin, Hyun-Il, Bang, Joo-In, Kim, Geun-Jeon, Kim, Mi Ra, Sun, Dong-Il, Kim, Sang-Yeon“…Thirty-one of the 41 patents (75.7%) exhibited a depressed mood, whereas more than 67.8% of the patients exhibited anxiety. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8730por Nakamura, Jutaro, Kamao, Tomoyuki, Mitani, Arisa, Mizuki, Nobuhisa, Shiraishi, Atsushi“…The degree of obstruction was classified into patent, partial obstruction, and complete obstruction. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8731por Wan, Qi, Ren, Xiang, Wei, Ran, Yue, Shali, Wang, Lixiang, Yin, Hongbo, Tang, Jing, Zhang, Ming, Ma, Ke, Deng, Ying-ping“…CONCLUSIONS: Our findings suggest that DL model can accurately predict vital status in UM patents just using histopathological images. We found out two subgroups based on histopathological DL features, which may in favor of immunotherapy and chemotherapy. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8732por Phakathi, Boitumelo, Dix-Peek, Therese, Van Den Berg, Eunice, Dickens, Caroline, Nietz, Sarah, Cubasch, Herbert, Joffe, Maureen, Neugut, Alfred I., Jacobson, Judith S., Ruff, Paul, Duarte, Raquel“…HIV-positive patients with luminal A & B subtypes had significantly worse survival outcomes than HIV-negative luminal patents. CONCLUSION: Aggressive tumour biology was common in our cohort. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8733por Marc, Isabelle, Lavoie, Pascal M, McPhee, Andrew J, Collins, Carmel T, Simonyan, David, Pronovost, Etienne, Guillot, Mireille, Gould, Jacqueline F, Mohamed, Ibrahim, Beltempo, Marc, Boutin, Amélie, Fortier, Isabel, Sullivan, Thomas R, Moore, Lynne, Makrides, Maria“…Other outcomes will be survival without severe BPD, death, BPD severity grades, serious brain injury, severe retinopathy of prematurity, patent ductus arteriosus and necrotising enterocolitis requiring surgery, sepsis, combined neonatal morbidities and growth. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8734por Gunasekaran, Pradeep Kumar, Shanmugasundaram, Devika, Santhanam, Sridhar, Verma, Sanjay, Singh, Kuldeep, Dwibedi, Bhagirathi, Awasthi, Shally, Singh, Himabindu, Sangappa, Mahantesh, Mondal, Nivedita, Sreenivasan, Priya, Saradakutty, Geetha, Malik, Shikha, Jain, Manish, Viswanathan, Rajlakshmi, Sapkal, Gajanan, Tripathi, Shalini, Patel, Bhupeshwari, Jain, Mahendra Kumar, Naganur, Sanjeev Hanumantacharya, Baranwal, Arun, Rohit, Manoj K, Deora, Surender, Sharma, Akhil, Anantharaj, Avinash, Pillai, Lakshmi Sadasivan, Kumar, Amber, Ramasamy, Sabarinathan, Rajendran, Padma Priya, Singh, Mini P., Ratho, Radha Kanta, Nag, Vijaylakshmi, Gadepalli, Ravishekhar, Mishra, Baijayantimala, Som, Tapas Kumar, Jain, Amita, Devara, Sudha Madhuri, Vannavada, Sudha Rani, Munivenkatappa, Ashok, Abraham, Asha Mary, Dhodapkar, Rahul, Ali, Syed, Biswas, Debasis, Pratkeye, Deepashri, Bavdekar, Ashish, Prakash, Jayant, Ray, Jaydeb, Murhekar, Manoj“…FINDINGS: Of the 4578 suspected CRS cases enrolled by 14 sites, 558 (12.2%) were laboratory confirmed. 419 (75.1%) laboratory confirmed cases had structural heart defects (simple defects: n = 273, 65.2%, complex defects: n = 144, 34.4%), with ventricular septal defect (42.7%), atrial septal defect (39.4%), patent ductus arteriosus (36.5%), and tetralogy of Fallot as the commonest defects (4.5%). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8735por Kiely, Melissa J, Poulsen, Ashleigh, Muschamp, Simon D, Sallis, Chloe, Whiteley, Mark S“…A new compression garment with patented “vari-pad” technology has been developed, aiming to stimulate lymphatic return from the buttocks and thighs. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8736por Chua, Winnie, Cardoso, Victor R., Guasch, Eduard, Sinner, Moritz F., Al-Taie, Christoph, Brady, Paul, Casadei, Barbara, Crijns, Harry J. G. M., Dudink, Elton A. M. P., Hatem, Stéphane N., Kääb, Stefan, Kastner, Peter, Mont, Lluis, Nehaj, Frantisek, Purmah, Yanish, Reyat, Jasmeet S., Schotten, Ulrich, Sommerfeld, Laura C., Zeemering, Stef, Ziegler, André, Gkoutos, Georgios V., Kirchhof, Paulus, Fabritz, Larissa“…Twelve biomarkers identified by reviewing literature and patents were quantified on a high-precision, high-throughput platform in 1485 consecutive patients with cardiovascular conditions (median age 69 years [Q1, Q3 60, 78]; 60% male). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8737“…PARTICIPANTS AND DATA COLLECTION: Data were collected through: (1) two in-depth interviews (IDIs) with LGA healthcare managers; (2) six IDIs with LGA adolescent health programme managers; (3) two focus group discussions (FGDs) with 15 primary healthcare facility managers; (4) two FGDs with 20 patent medicine vendors and (5) two FGDs with 17 community health volunteers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8738por Sersa, G, Jarm, T, Kotnik, T, Coer, A, Podkrajsek, M, Sentjurc, M, Miklavcic, D, Kadivec, M, Kranjc, S, Secerov, A, Cemazar, M“…The vascular effect was determined by laser Doppler flowmetry, power Doppler ultrasonographic imaging and Patent blue staining. The extent of tumour hypoxia was determined immunohistochemically by hypoxia marker pimonidazole and partial pressure of oxygen (pO(2)) in tumours by electron paramagnetic resonance oximetry. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
8739por Cho, Jung Sun, Kim, Kye Hun, Lee, Woo Seok, Yoon, Hyun Ju, Yoon, Nam Sik, Hong, Young Joon, Park, Hyung Wook, Kim, Ju Han, Ahn, Youngkeun, Jeong, Myung Ho, Cho, Jeong Gwan, Park, Jong Chun, Kang, Jung Chaee“…METHODS: Sixty-nine patients with acute myocardial infarction (AMI) who underwent successful primary PCI were divided into two groups; the patients with occlusion of IRA (Group I, 41 patients, 63.0 ± 14.9 years of age, 31 males) versus the patients with patent IRA (Group II, 28 patients, 63.8 ± 11.2 years of age, 15 males). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
8740por Chen, Ni-Ni, Han, Mei, Yang, Hong, Yang, Guo-Yan, Wang, Yu-Yi, Wu, Xiao-Ke, Liu, Jian-Ping“…We included randomised controlled trials (RCTs) that tested Guizhi Fuling Formula for uterine fibroids, compared with no intervention, placebo, pharmaceutical medication, or other Chinese patent medicines approved by the State Food and Drug Administration of China. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto